With this overwhelming evidence in support of COX-2 involvement in breast cancer metastasis, we chose to analyze COX-2 overexpression as an indicator of metastatic potential of in vitro selected metabolically plastic cancer cells, prior to xenograft experiment in nude mice. The gene discussed is PTGS2; the disease is breast carcinoma.